上海瑞亦康生物科技有限公司是一家在港投资的合资公司，是由辉荣集团有限公司和吉瑞有限公司组成。专注于转化和再生医学。
2011年10月，我们与上海复旦大学华山医院合作，进行自体细胞培养研究与生产。已经在皮肤再生领域作出了非常可喜的成绩。这种非常有吸引力的皮肤细胞培养技术，可以治疗一些疾病如白癜风和烧伤等。
公司具有一个团结，合作，勤奋，有凝聚力的团队，每个成员都会根据自己目标努力工作并最终实现目标。我们公司虽然还很年轻，但是我们每位员工都有同一个目标，积极准备，准备飞起来，成为一个全球化公司。
Shanghai R&M Biotechnology Co. Ltd., a foreign invested company, is established in April, 2013 as a joint venture of Shanghai ReMed Biotechnology, Co. Ltd. and Menicon Co. Ltd., focusing on translational and regenerative medicine.
The basement of our challenge has been laid in the field of skin regeneration since our company started to collaborate with Huashan hospital at Fudan University, Shanghai, in Oct 2011. Because it has now a very attractive technology to produce skin cell sheet, we can apply this technology to rescue some diseases such as vitiligo and burn.
R&M has strong teams based on each project, and the members are very collaborative and hard-working toward achieving our goal. Although our company is still young, we are ready to fly, aiming to become a global company.
地 址：静安区愚园路172号环球世界大厦1708室
邮政编码：200040
